insights_auto
Why is VTVT up 3.26%?
Dive Deeperchevron_right
VTVT:NASDAQ
vTv Therapeutics Inc
$ 31.01
arrow_upward
+3.26%(+0.98) 1D
$ 32.71
arrow_upward
+5.50% (+1.70)bedtimeAfter hours
Closed: 10-р сарын 7, 16:00:00 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VTVT...
Open
$ 29.95
High
$ 31.50
Low
$ 29.86
Mkt. cap
122.61 сая
Avg. vol.
45.39 мян
Volume
3.00
52-wk high
$ 44.00
52-wk low
$ 19.80
EPS
-$ 1.06
Beta
0.23
Shares outstanding
3.95 сая
No. of employees
26
Open
$ 29.95
High
$ 31.50
Low
$ 29.86
Mkt. cap
122.61 сая
Avg. vol.
45.39 мян
Volume
3.00
52-wk high
$ 44.00
52-wk low
$ 19.80
EPS
-$ 1.06
Beta
0.23
Shares outstanding
3.95 сая
No. of employees
26
News stories
From web sources and news partners
Stock Titan
·
12 цагийн өмнө
About 100,000 people in the U.S. have sickle cell disease. FDA gives vTv's drug candidate a rare-disease designation.
GuruFocus
·
19 цагийн өмнө
vTv Therapeutics (VTVT) Completes Enrollment for Phase 3 Trial o
MarketBeat
·
22 цагийн өмнө
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Stock Titan
·
2 өдрийн өмнө
A type 1 diabetes drug trial has enrolled 166 people. Results are expected in mid-2027.
About vTv Therapeutics Inc
CEO-
Employees26
Founded2015
HeadquartersХай Пойнт, Хойд Каролина, Америкийн Нэгдсэн Улс
Sector-
Websitevtvtherapeutics.com